Albertsons questions bound of Washington’s pharmacy regulations
In week two of Washington’s trial against Albertsons, experts discussed “red flags” pharmacists are trained to identify.
Catheter fractures
PHOENIX — An Arizona federal court denied a medical technology company’s motion for summary judgment in a multidistrict personal injury case arising from allegations that its port catheters are defective. One of the suing patients presented evidence the company knew their port catheters commonly fracture, and that the risk of catheter fracture is “catastrophic and life-threatening.”
Arkansas accuses pharma companies of plot to undermine federal drug discount program
340B is a federal program that requires pharma companies to provide discounted drugs for hospitals and clinics that serve low-income and underserved populations.
